The following articles (labelled with PubMed ID or TBD) are for your review
PMID | Data | Article Title | Organization |
6313919 |
6 |
C4-substituted 1-beta-D-ribofuranosylpyrazolo[3,4-d]pyrimidines as adenosine agonist analogues. |
TBA |
27485602 |
183 |
Similarities and differences in affinity and binding modes of tricyclic pyrimido- and pyrazinoxanthines at human and rat adenosine receptors. |
Jagiellonian University Medical College |
26638043 |
66 |
Structural refinement of pyrazolo[4,3-d]pyrimidine derivatives to obtain highly potent and selective antagonists for the human A3 adenosine receptor. |
Universit£ |
24164628 |
186 |
Adenosine A2A receptor as a drug discovery target. |
Merck Research Laboratories |
22468757 |
171 |
Medicinal chemistry of A3 adenosine receptor modulators: pharmacological activities and therapeutic implications. |
Universit£ |
21664729 |
142 |
Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones. |
Jagiellonian University Medical College |
22486652 |
44 |
Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening. |
National Institute of Diabetes and Digestive and Kidney Diseases |
20188574 |
141 |
2-Amino-5-benzoyl-4-phenylthiazoles: Development of potent and selective adenosine A1 receptor antagonists. |
University of Bonn |
19569717 |
251 |
1-alkyl-8-(piperazine-1-sulfonyl)phenylxanthines: development and characterization of adenosine A2B receptor antagonists and a new radioligand with subnanomolar affinity and subtype specificity. |
Institute |
18424135 |
131 |
Design of (N)-methanocarba adenosine 5'-uronamides as species-independent A3 receptor-selective agonists. |
National Institute of Diabetes and Digestive and Kidney Diseases |
18255292 |
35 |
Structure-activity relationships of 2-chloro-N6-substituted-4'-thioadenosine-5'-N,N-dialkyluronamides as human A3 adenosine receptor antagonists. |
Ewha Womans University |
15990306 |
4 |
BCUT descriptors to predicting affinity toward A3 adenosine receptors. |
Experimental Sugar Cane Station&Quot;Villa Clara-Cienfuegos&Quot |
12930138 |
1 |
N6-substituted D-4'-thioadenosine-5'-methyluronamides: potent and selective agonists at the human A3 adenosine receptor. |
Ewha Womans University |
11881988 |
16 |
Ribose-modified nucleosides as ligands for adenosine receptors: synthesis, conformational analysis, and biological evaluation of 1'-C-methyl adenosine analogues. |
Universit£ |
12238926 |
99 |
Structural determinants of A(3) adenosine receptor activation: nucleoside ligands at the agonist/antagonist boundary. |
National Institute of Diabetes and Digestive and Kidney Diseases |
11708915 |
52 |
Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. |
National Institute of Diabetes and Digestive and Kidney Diseases |
11170630 |
46 |
Nucleosides and nucleotides. 200. Reinvestigation of 5'-N-ethylcarboxamidoadenosine derivatives: structure-activity relationships for P(3) purinoceptor-like proteins. |
Hokkaido University |
10956189 |
98 |
A novel class of highly potent and selective A1 adenosine antagonists: structure-affinity profile of a series of 1,8-naphthyridine derivatives. |
Universit£ |
10841798 |
64 |
Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. |
National Institute of Diabetes |
10212124 |
26 |
5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors. |
Leiden University |
9703464 |
40 |
Structure-activity relationships and molecular modeling of 3, 5-diacyl-2,4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
9703463 |
102 |
Synthesis and biological activity of a new series of N6-arylcarbamoyl, 2-(Ar)alkynyl-N6-arylcarbamoyl, and N6-carboxamido derivatives of adenosine-5'-N-ethyluronamide as A1 and A3 adenosine receptor agonists. |
Universit£ |
9667957 |
5 |
Nucleosides and nucleotides. 177. 9-(6,7-dideoxy-beta-D-allo-hept-5- ynofuranosyl)adenine: a selective and potent ligand for P3 purinoceptor-like protein. |
Hokkaido University |
9572897 |
49 |
2'-C-Methyl analogues of selective adenosine receptor agonists: synthesis and binding studies. |
Universit£ |
8576924 |
69 |
Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors. |
Universit£ |
8709132 |
92 |
Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. |
National Institute of Diabetes |
7707320 |
99 |
Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. |
National Institute of Diabetes |
7752196 |
103 |
Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors. |
National Institute of Diabetes |
8126704 |
79 |
Structure-activity relationships of N6-benzyladenosine-5'-uronamides as A3-selective adenosine agonists. |
National Institute of Diabetes |
7966162 |
39 |
Selective ligands for rat A3 adenosine receptors: structure-activity relationships of 1,3-dialkylxanthine 7-riboside derivatives. |
National Institute of Diabetes |
7932588 |
48 |
2-Substitution of N6-benzyladenosine-5'-uronamides enhances selectivity for A3 adenosine receptors. |
National Institute of Diabetes |
2441057 |
22 |
Binary drugs: conjugates of purines and a peptide that bind to both adenosine and substance P receptors. |
TBA |
6279840 |
53 |
Adenosine receptors: targets for future drugs. |
TBA |
12617898 |
13 |
Design, synthesis and binding affinity of 3'-fluoro analogues of Cl-IB-MECA as adenosine A3 receptor ligands. |
Seoul National University |
9873707 |
18 |
Fluorescent probes for adenosine receptors: synthesis and biology of N6-dansylaminoalkyl-substituted NECA derivatives. |
Glaxowellcome Medicines Research Center |
19879151 |
58 |
Design and synthesis of N(6)-substituted-4'-thioadenosine-5'-uronamides as potent and selective human A(3) adenosine receptor agonists. |
Ewha Womans University |
19499950 |
64 |
Functionalized congeners of A3 adenosine receptor-selective nucleosides containing a bicyclo[3.1.0]hexane ring system. |
National Institute of Diabetes and Digestive and Kidney Diseases |
19375920 |
30 |
Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists. |
Ewha Womans University |
18811138 |
41 |
Structure-activity relationships of truncated D- and l-4'-thioadenosine derivatives as species-independent A3 adenosine receptor antagonists. |
Ewha Womans University |
17149867 |
51 |
2-triazole-substituted adenosines: a new class of selective A3 adenosine receptor agonists, partial agonists, and antagonists. |
Ghent University |
16366590 |
12 |
Semi-rational design of (north)-methanocarba nucleosides as dual acting A(1) and A(3) adenosine receptor agonists: novel prototypes for cardioprotection. |
National Institute of Diabetes and Digestive and Kidney Diseases |
16356715 |
32 |
A topological function based on spectral moments for predicting affinity toward A3 adenosine receptors. |
Vigo University |
16289820 |
14 |
Conversion of A3 adenosine receptor agonists into selective antagonists by modification of the 5'-ribofuran-uronamide moiety. |
National Institute of Diabetes and Digestive and Kidney Diseases |
15771421 |
96 |
(N)-methanocarba 2,N6-disubstituted adenine nucleosides as highly potent and selective A3 adenosine receptor agonists. |
National Institute of Diabetes and Digestive and Kidney Diseases |
12166930 |
21 |
Synthesis, biological properties, and molecular modeling investigation of the first potent, selective, and water-soluble human A(3) adenosine receptor antagonist. |
TBA |
11087559 |
7 |
Design, radiosynthesis, and biodistribution of a new potent and selective ligand for in vivo imaging of the adenosine A(2A) receptor system using positron emission tomography. |
University of Milano-Bicocca |
10737749 |
182 |
Anilide derivatives of an 8-phenylxanthine carboxylic congener are highly potent and selective antagonists at human A(2B) adenosine receptors. |
National Institute of Diabetes |
10052977 |
82 |
Synthesis, CoMFA analysis, and receptor docking of 3,5-diacyl-2, 4-dialkylpyridine derivatives as selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
30605331 |
236 |
Design and in Vivo Characterization of A |
Medical College of Wisconsin |
30835463 |
202 |
A |
Rheinische Friedrich-Wilhelms-Universitat Bonn |
9258367 |
99 |
Structure-activity relationships of 4-(phenylethynyl)-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists. |
National Institute of Diabetes |
8863790 |
55 |
Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype. |
National Institute of Diabetes |
8691424 |
61 |
Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. |
National Institute of Diabetes |
8558508 |
55 |
Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. |
National Institute of Diabetes |
24456490 |
33 |
Synthesis and anti-renal fibrosis activity of conformationally locked truncated 2-hexynyl-N(6)-substituted-(N)-methanocarba-nucleosides as A3 adenosine receptor antagonists and partial agonists. |
Seoul National University |
24139167 |
419 |
1,3-Dialkyl-substituted tetrahydropyrimido[1,2-f]purine-2,4-diones as multiple target drugs for the potential treatment of neurodegenerative diseases. |
University of Bonn |
7932565 |
92 |
Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors. |
National Institute of Diabetes |
29681156 |
71 |
Fluorescent-Labeled Selective Adenosine A |
University of Bonn |
28447789 |
134 |
Exploring the Role of N |
University of Camerino |